Your browser doesn't support javascript.
loading
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors.
Martin, Alexandra L; Anadon, Carmen M; Biswas, Subir; Mine, Jessica A; Handley, Katelyn F; Payne, Kyle K; Mandal, Gunjan; Chaurio, Ricardo A; Powers, John J; Sprenger, Kimberly B; Rigolizzo, Kristen E; Innamarato, Patrick; Harro, Carly M; Mehta, Sumit; Perez, Bradford A; Wenham, Robert M; Conejo-Garcia, Jose R.
Affiliation
  • Martin AL; Department of Clinical Science, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Anadon CM; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Biswas S; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Mine JA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Handley KF; Gynecologic Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Payne KK; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Mandal G; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Chaurio RA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Powers JJ; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Sprenger KB; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Rigolizzo KE; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Innamarato P; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Harro CM; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Mehta S; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Perez BA; Gynecologic Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Wenham RM; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Conejo-Garcia JR; Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Mol Cancer Ther ; 21(7): 1184-1194, 2022 07 05.
Article in En | MEDLINE | ID: mdl-35499393
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Receptors, Odorant / Neoplasms, Glandular and Epithelial / Lung Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Receptors, Odorant / Neoplasms, Glandular and Epithelial / Lung Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2022 Document type: Article Country of publication: Estados Unidos